Pharmacologic overview of Withania somnifera, the Indian Ginseng

被引:203
作者
Dar, Nawab John [1 ,2 ,3 ]
Hamid, Abid [2 ,3 ]
Ahmad, Muzamil [1 ,3 ]
机构
[1] Indian Inst Integrat Med CSIR, Neuropharmacol Lab, Srinagar 190005, Jammu & Kashmir, India
[2] Indian Inst Integrat Med CSIR, Canc Pharmacol Div, Jammu 180001, India
[3] Indian Inst Integrat Med CSIR, Acad Sci & Innovat Res AcSIR, Jammu 180001, Jammu & Kashmir, India
关键词
Withania somnifera; Anti-bacterial; Anti-inflammatory; Anti-arthritic; Anti-cancer; Cardio-protective; Anti-diabetic; Anti-stress; Parkinson's disease; Alzheimer's disease; Stroke hypoxia; NF-KAPPA-B; ROOT EXTRACT; IN-VITRO; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; WITHAFERIN-A; STEROIDAL LACTONES; ANTILEISHMANIAL ACTIVITY; HERBAL FORMULATION; INDUCED ARTHRITIS;
D O I
10.1007/s00018-015-2012-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Withania somnifera, also called 'Indian ginseng', is an important medicinal plant of the Indian subcontinent. It is widely used, singly or in combination, with other herbs against many ailments in Indian Systems of Medicine since time immemorial. Withania somnifera contains a spectrum of diverse phytochemicals enabling it to have a broad range of biological implications. In preclinical studies, it has shown anti-microbial, anti-inflammatory, anti-tumor, anti-stress, neuroprotective, cardioprotective, and anti-diabetic properties. Additionally, it has demonstrated the ability to reduce reactive oxygen species, modulate mitochondrial function, regulate apoptosis, and reduce inflammation and enhance endothelial function. In view of these pharmacologic properties, W. somnifera is a potential drug candidate to treat various clinical conditions, particularly related to the nervous system. In this review, we summarize the pharmacologic characteristics and discuss the mechanisms of action and potential therapeutic applications of the plant and its active constituents.
引用
收藏
页码:4445 / 4460
页数:16
相关论文
共 182 条
[1]  
Abou-Douh AM, 2002, ARCH PHARM, V335, P267, DOI 10.1002/1521-4184(200208)335:6<267::AID-ARDP267>3.0.CO
[2]  
2-E
[3]   Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation [J].
Agarwal, R ;
Diwanay, S ;
Patki, P ;
Patwardhan, B .
JOURNAL OF ETHNOPHARMACOLOGY, 1999, 67 (01) :27-35
[4]   Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats [J].
Ahmad, M ;
Saleem, S ;
Ahmad, AS ;
Ansari, MA ;
Yousuf, S ;
Hoda, MN ;
Islam, F .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2005, 24 (03) :137-147
[5]   Attenuation of oxidative damage-associated cognitive decline by Withania somnifera in rat model of streptozotocin-induced cognitive impairment [J].
Ahmed, Md Ejaz ;
Javed, Hayate ;
Khan, Mohd Moshahid ;
Vaibhav, Kumar ;
Ahmad, Ajmal ;
Khan, Andleeb ;
Tabassum, Rizwana ;
Islam, Farah ;
Safhi, Mohammed M. ;
Islam, Fakhrul .
PROTOPLASMA, 2013, 250 (05) :1067-1078
[6]   Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities [J].
Alam, Nadia ;
Hossain, Monzur ;
Mottalib, Md Abdul ;
Sulaiman, Siti Amrah ;
Gan, Siew Hua ;
Khalil, Md Ibrahim .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 12
[7]   Withanolides from the stem bark of Withania somnifera [J].
Ali, M ;
Shuaib, M ;
Ansari, SH .
PHYTOCHEMISTRY, 1997, 44 (06) :1163-1168
[8]  
Andallu B., 2000, Indian Journal of Experimental Biology, V38, P607
[9]  
Anjaneyulu ASR, 1998, STUD NAT PROD CHEM, V20, P135
[10]  
[Anonymous], MAKHZAN UL MUFRADAT